Elizabeth Holmes, Founder, CEO
Elizabeth A. Holmes is President and Chief Executive Officer of Theranos, Inc. Holmes’ unique background in microfluidics and nanotechnology led her to found Theranos around her patent, Medical Device for Analyte Monitoring and Drug Release, and the vision to create a new sector of personalized health care enabling individuals to take control of their health through real-time diagnosis, monitoring, and treatment of targeted ailments in a non-invasive fashion. She took the company from concept to reality, building a world-class management team and leading the product and commercial development infrastructures from inception through to manufacturing for pharmaceutical partners today. Holmes left Stanford University to found Theranos after contributing to the development of several novel biosensor systems through her work at Genome Institute Singapore and in collaboration with Genencor International.